OTC wart removers
This article was originally published in The Tan Sheet
Executive Summary
FDA proposes a change in monograph labeling for OTC wart remover products containing 15% salicylic acid in a karaya gum, glycol plaster vehicle to include new directions for use. In a proposed rule appearing in the Jan. 28 Federal Register, FDA adds directions for use of an emery file and advises consumers to "apply a drop of warm water to the wart" prior to applying the medicated plaster. FDA noted that the only company currently marketing such a product has added these directions to product labeling. The agency said it is proposing the labeling change in order to avoid "consumer confusion" if other products, such as private labels, are using the current final monograph directions for use
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning